BioStem Technologies to Present at the Annual Needham Conference
POMPANO BEACH, Fla. -- BioStem Technologies, Inc. (OTC: BSEM), a pioneering MedTech company dedicated to the development and commercialization of placental-derived products designed for advanced wound care, has exciting news. Jason Matuszewski, the company's Chief Executive Officer, will deliver a presentation at the prestigious 24th Annual Needham Virtual Healthcare Conference. Attendees can look forward to this insightful session scheduled for 1:30 PM ET on April 10, 2025. Additionally, the management team will be engaging in investor meetings throughout the conference.
What to Expect from the Presentation
Details of the Presentation
Jason Matuszewski will lead the presentation, sharing the latest updates on BioStem Technologies’ innovative solutions focused on utilizing perinatal tissue. This concentrated effort is not only aimed at improving wound care but also enhancing the quality of life for patients dealing with severe injuries.
Accessing the Presentation
The presentation will be available via a webcast, providing an opportunity for all interested participants to gain insights into the advancements in MedTech and the unique approaches BioStem Technologies is taking. Following the live presentation, an archive of the session will be accessible for those who wish to review it at a later time.
Investing in Health Innovation
BioStem Technologies is redefining standards in the medical technology sector with a commitment to providing efficient and effective treatment options through its various placental allografts. This includes their proprietary BioREtain processing method that retains essential growth factors and preserves tissue structure. Each product is manufactured under stringent quality controls, accredited by the American Association of Tissue Banks (AATB), adhering to industry best practices.
The Impact of BioStem’s Innovations
Each allograft developed is aimed at providing real-world solutions for complex health issues. BioStem’s diverse range of products includes branded items like AmnioWrap²™, VENDAJE®, and more, which are designed to cater to different medical needs in wound care management. The recent push by the company into more innovative avenues, like integrating advanced processing techniques, showcases their leadership in the field.
Engaging with BioStem Technologies
For those interested in staying updated with the latest innovations and announcements from BioStem Technologies, there are several ways to connect. Individuals can join the company's email distribution list, follow them on social media platforms like X, and access detailed information on their efforts to revolutionize the sector. Consistent updates highlight the advancements and important milestones of BioStem Technologies.
Contacting BioStem Technologies
Should you have inquiries or require further information about their initiatives, feel free to reach out directly. BioStem encourages communication through their investor relations email or by phone for prompt assistance.
Frequently Asked Questions
1. What is the focus of BioStem Technologies?
BioStem Technologies focuses on developing advanced wound care products derived from placental tissue to improve patient outcomes.
2. When will the presentation take place?
The presentation is scheduled for April 10, 2025, at 1:30 PM ET during the Needham Virtual Healthcare Conference.
3. How can I access the presentation?
The presentation will be available via a webcast and archived for future viewing.
4. What products does BioStem offer?
BioStem offers a range of placental allografts including AmnioWrap²™, VENDAJE®, and more, aimed at facilitating advanced wound care.
5. How can I keep updated with BioStem's activities?
You can join their email list, follow them on social media, or check their website for the latest news and updates.
